SOURCE: Market Pulse

April 07, 2005 08:30 ET

Market Pulse Breaking News Alert for Thursday, April 7, 2005: BIPH -- Biophan Announces Availability of New 50% Smaller Model of MRI-Safe Ceramic SQUIGGLE® Motor for Medical Uses!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- April 7, 2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Biophan Technologies, Inc. (OTC BB: BIPH), Nyer Medical Group, Inc. (NASDAQ: NYER), Microsoft Corp. (NASDAQ: MSFT), and MCI Inc. (NASDAQ: MCIP).

Investors need to be watching Biophan Technologies, Inc. (OTC BB: BIPH) this AM! Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. Biophan's technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. BIPH had great news out in a press release before today's opening bell regarding the development of a new, ultra-small model of the implantable and wearable, highly precise ceramic SQUIGGLE motor! Investors should be watching this one closely!

Biophan Technologies, Inc. (OTC BB: BIPH), a developer of next-generation biomedical technology, has announced the development of a new, ultra-small model of the implantable and wearable, highly precise ceramic SQUIGGLE motor that's half the size of previous models, with significant improvements in precision and electrical efficiency compared to electromagnetic motors.

Biophan holds the exclusive worldwide distribution rights to all medical applications of the SQUIGGLE motor, produced by New Scale Technologies. SQUIGGLE linear motors are five times more efficient and ten times more precise compared to electromagnetic motors. Biophan has been working with New Scale to develop medical applications for the proprietary motor for the $40 billion-plus market for drug delivery products.

"The SQUIGGLE motor's unique features and capabilities offer a number of important advantages as a pump to drive drug delivery systems, catheters, and other potential medical applications that require the highest levels of precision and dependability," said Michael Weiner, CEO of Biophan. "Additionally, because the SQUIGGLE is made from non-magnetic ceramic materials, it is compatible with Magnetic Resonance Imaging (MRI) environments. That means that patients who receive either the implanted or wearable SQUIGGLE-based drug delivery systems can be effectively imaged by MRI systems, allowing physicians and patients to receive the many important benefits of MRI imaging."

SQUIGGLE motors use only four parts -- about 90% fewer parts than most gear-based and other medical device motors. Because they require no gear reduction, a significant source of failure and malfunction is eliminated, increasing the SQUIGGLE's dependability, about the size of a dime (see photo at http://www.biophan.com/NewScale.jpg). The new SQUIGGLE SQ-306 model is 10 mm in length and 4 mm in diameter, and achieves precision levels in the nanometer-range. The motor's improved power efficiency leads to longer battery life -- a critical factor for implanted medical devices where replacements require surgical procedures. The motor's mechanical design is simple and inherently inexpensive to manufacture in high quantities, having only four parts, compared with as many as 100 parts for other biomedical motor technologies.

"At Biophan we are very pleased with the progress of New Scale, both as the exclusive distributor in the medical market, and as a minority equity owner in New Scale. New Scale has sales approaching $1 million in the market for cryogenic motors, and has an enormous potential in the emerging market for optical zoom in future cell phones," stated Mr. Weiner. "Their robust R&D and expanding patent portfolio comes at virtually no cost to us, but adds enormous value to our company. There is also an opportunity for Biophan to supply MRI safe motors that have the ability to function in cryogenic environments."

About New Scale Technologies

New Scale Technologies, Inc. makes miniature motors and precision positioning systems that are cost effective, powerful, and efficient for emerging applications in nanotechnology, microelectronics, optics, lasers, biotechnology, medical devices, aerospace and defense, fluid control, and office/consumer products. The company is privately held, located in Victor, NY and was founded in 2002 by David Henderson. The New Scale team has more than 100 years of combined experience with precision positioning and piezoelectric ceramic motors including their technologies, markets, applications, and customers. For more information, please visit www.newscaletech.com.

About Biophan Technologies

Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers and interventional surgical devices such as catheters, guidewires, stents, and other implants to allow them to be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 114 U.S. patents, licenses, or applications. This total includes 36 issued U.S. patents, 6 recently allowed applications that will issue as patents in the near future, and 72 pending applications at various stages of examination at the U.S. Patent and Trademark Office, plus international applications. The patents cover areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life. For more information, please visit www.biophan.com.

Stocks acting well as of late include: Nyer Medical Group, Inc. (NASDAQ: NYER), Microsoft Corp. (NASDAQ: MSFT), and MCI Inc. (NASDAQ: MCIP).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated seventy five thousand dollars from Biophan Technologies, Inc. An additional twenty five thousand dollars is pending from Biophan Technologies, Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.

Contact Information